United States Gene-Deleted Vaccines Market Report 2016

Publisher Name :
Date: 13-Sep-2016
No. of pages: 124
Inquire Before Buying

Notes:

Sales, means the sales volume of Gene-Deleted Vaccines

Revenue, means the sales value of Gene-Deleted Vaccines

This report studies sales (consumption) of Gene-Deleted Vaccines in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Bayer HealthCare AG (Germany)

- Biogenesis-Bago (Argentina)

- Boehringer Ingelheim GmbH (Germany)

- Ceva Sante Animale (France)

- Heska Corporation (US)

- Indian Immunologicals Ltd (India)

- Lohmann Animal Health (US)

- Merck Animal Health (US)

- Merial Ltd. (US)

- Protein Sciences Corporation (US)

- Virbac SA (France)

- Zoetis Inc. (US)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Gene-Deleted Vaccines in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Gene-Deleted Vaccines Market Report 2016

Table of Contents
United States Gene-Deleted Vaccines Market Report 2016
1 Gene-Deleted Vaccines Overview
1.1 Product Overview and Scope of Gene-Deleted Vaccines
1.2 Classification of Gene-Deleted Vaccines
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Gene-Deleted Vaccines
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Gene-Deleted Vaccines (2011-2021)
1.4.1 USA Gene-Deleted Vaccines Sales and Growth Rate (2011-2021)
1.4.2 USA Gene-Deleted Vaccines Revenue and Growth Rate (2011-2021)
2 USA Gene-Deleted Vaccines Competition by Manufacturers
2.1 USA Gene-Deleted Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Gene-Deleted Vaccines Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Gene-Deleted Vaccines Average Price by Manufactures (2015 and 2016)
2.4 Gene-Deleted Vaccines Market Competitive Situation and Trends
2.4.1 Gene-Deleted Vaccines Market Concentration Rate
2.4.2 Gene-Deleted Vaccines Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 USA Gene-Deleted Vaccines Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 USA Gene-Deleted Vaccines Sales and Market Share by Type (2011-2016)
3.2 USA Gene-Deleted Vaccines Revenue and Market Share by Type (2011-2016)
3.3 USA Gene-Deleted Vaccines Price by Type (2011-2016)
3.4 USA Gene-Deleted Vaccines Sales Growth Rate by Type (2011-2016)
4 USA Gene-Deleted Vaccines Sales (Volume) by Application (2011-2016)
4.1 USA Gene-Deleted Vaccines Sales and Market Share by Application (2011-2016)
4.2 USA Gene-Deleted Vaccines Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 USA Gene-Deleted Vaccines Manufacturers Profiles/Analysis
5.1 Bayer HealthCare AG (Germany)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Gene-Deleted Vaccines Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Bayer HealthCare AG (Germany) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Biogenesis-Bago (Argentina)
5.2.2 Gene-Deleted Vaccines Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Biogenesis-Bago (Argentina) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Boehringer Ingelheim GmbH (Germany)
5.3.2 Gene-Deleted Vaccines Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Boehringer Ingelheim GmbH (Germany) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Ceva Sante Animale (France)
5.4.2 Gene-Deleted Vaccines Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Ceva Sante Animale (France) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Heska Corporation (US)
5.5.2 Gene-Deleted Vaccines Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Heska Corporation (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Indian Immunologicals Ltd (India)
5.6.2 Gene-Deleted Vaccines Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Indian Immunologicals Ltd (India) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Lohmann Animal Health (US)
5.7.2 Gene-Deleted Vaccines Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Lohmann Animal Health (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Merck Animal Health (US)
5.8.2 Gene-Deleted Vaccines Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Merck Animal Health (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Merial Ltd. (US)
5.9.2 Gene-Deleted Vaccines Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Merial Ltd. (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Protein Sciences Corporation (US)
5.10.2 Gene-Deleted Vaccines Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Protein Sciences Corporation (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Virbac SA (France)
5.12 Zoetis Inc. (US)
6 Gene-Deleted Vaccines Manufacturing Cost Analysis
6.1 Gene-Deleted Vaccines Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Gene-Deleted Vaccines
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Gene-Deleted Vaccines Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Gene-Deleted Vaccines Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 USA Gene-Deleted Vaccines Market Forecast (2016-2021)
10.1 USA Gene-Deleted Vaccines Sales, Revenue Forecast (2016-2021)
10.2 USA Gene-Deleted Vaccines Sales Forecast by Type (2016-2021)
10.3 USA Gene-Deleted Vaccines Sales Forecast by Application (2016-2021)
10.4 Gene-Deleted Vaccines Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Gene-Deleted Vaccines
Table Classification of Gene-Deleted Vaccines
Figure USA Sales Market Share of Gene-Deleted Vaccines by Type in 2015
Table Application of Gene-Deleted Vaccines
Figure USA Sales Market Share of Gene-Deleted Vaccines by Application in 2015
Figure USA Gene-Deleted Vaccines Sales and Growth Rate (2011-2021)
Figure USA Gene-Deleted Vaccines Revenue and Growth Rate (2011-2021)
Table USA Gene-Deleted Vaccines Sales of Key Manufacturers (2015 and 2016)
Table USA Gene-Deleted Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Gene-Deleted Vaccines Sales Share by Manufacturers
Figure 2016 Gene-Deleted Vaccines Sales Share by Manufacturers
Table USA Gene-Deleted Vaccines Revenue by Manufacturers (2015 and 2016)
Table USA Gene-Deleted Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Gene-Deleted Vaccines Revenue Share by Manufacturers
Table 2016 USA Gene-Deleted Vaccines Revenue Share by Manufacturers
Table USA Market Gene-Deleted Vaccines Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Gene-Deleted Vaccines Average Price of Key Manufacturers in 2015
Figure Gene-Deleted Vaccines Market Share of Top 3 Manufacturers
Figure Gene-Deleted Vaccines Market Share of Top 5 Manufacturers
Table USA Gene-Deleted Vaccines Sales by Type (2011-2016)
Table USA Gene-Deleted Vaccines Sales Share by Type (2011-2016)
Figure USA Gene-Deleted Vaccines Sales Market Share by Type in 2015
Table USA Gene-Deleted Vaccines Revenue and Market Share by Type (2011-2016)
Table USA Gene-Deleted Vaccines Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Gene-Deleted Vaccines by Type (2011-2016)
Table USA Gene-Deleted Vaccines Price by Type (2011-2016)
Figure USA Gene-Deleted Vaccines Sales Growth Rate by Type (2011-2016)
Table USA Gene-Deleted Vaccines Sales by Application (2011-2016)
Table USA Gene-Deleted Vaccines Sales Market Share by Application (2011-2016)
Figure USA Gene-Deleted Vaccines Sales Market Share by Application in 2015
Table USA Gene-Deleted Vaccines Sales Growth Rate by Application (2011-2016)
Figure USA Gene-Deleted Vaccines Sales Growth Rate by Application (2011-2016)
Table Bayer HealthCare AG (Germany) Basic Information List
Table Bayer HealthCare AG (Germany) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer HealthCare AG (Germany) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Biogenesis-Bago (Argentina) Basic Information List
Table Biogenesis-Bago (Argentina) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biogenesis-Bago (Argentina) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Boehringer Ingelheim GmbH (Germany) Basic Information List
Table Boehringer Ingelheim GmbH (Germany) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim GmbH (Germany) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Ceva Sante Animale (France) Basic Information List
Table Ceva Sante Animale (France) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ceva Sante Animale (France) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Heska Corporation (US) Basic Information List
Table Heska Corporation (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Heska Corporation (US) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Indian Immunologicals Ltd (India) Basic Information List
Table Indian Immunologicals Ltd (India) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Indian Immunologicals Ltd (India) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Lohmann Animal Health (US) Basic Information List
Table Lohmann Animal Health (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lohmann Animal Health (US) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Merck Animal Health (US) Basic Information List
Table Merck Animal Health (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Animal Health (US) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Merial Ltd. (US) Basic Information List
Table Merial Ltd. (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merial Ltd. (US) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Protein Sciences Corporation (US) Basic Information List
Table Protein Sciences Corporation (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Protein Sciences Corporation (US) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Virbac SA (France) Basic Information List
Table Virbac SA (France) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Virbac SA (France) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Zoetis Inc. (US) Basic Information List
Table Zoetis Inc. (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zoetis Inc. (US) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gene-Deleted Vaccines
Figure Manufacturing Process Analysis of Gene-Deleted Vaccines
Figure Gene-Deleted Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Gene-Deleted Vaccines Major Manufacturers in 2015
Table Major Buyers of Gene-Deleted Vaccines
Table Distributors/Traders List
Figure USA Gene-Deleted Vaccines Production and Growth Rate Forecast (2016-2021)
Figure USA Gene-Deleted Vaccines Revenue and Growth Rate Forecast (2016-2021)
Table USA Gene-Deleted Vaccines Production Forecast by Type (2016-2021)
Table USA Gene-Deleted Vaccines Consumption Forecast by Application (2016-2021)
  • Global Milk Allergy Clinical Trials Market Size, Status and Forecast 2022
    Published: 13-Dec-2017        Price: US 3300 Onwards        Pages: 93
    This report studies the global Milk Allergy Clinical Trials market, analyzes and researches the Milk Allergy Clinical Trials development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Mead Johnson - Danone SA - Perrigo Company - Abbott - Nestle - FrieslandCampina - Mylan - Sanofi - ALK Abello - Impax Market segment......
  • Global Intravenous Solutions Sales Market Report 2017
    Published: 13-Dec-2017        Price: US 4000 Onwards        Pages: 107
    In this report, the global Intravenous Solutions market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (Units), revenue (Million USD), market share and growth rate of Intravenous Solutions for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - ......
  • Global Overactive Bladder Drug Market Size, Status and Forecast 2022
    Published: 13-Dec-2017        Price: US 3300 Onwards        Pages: 101
    This report studies the global Overactive Bladder Drug market, analyzes and researches the Overactive Bladder Drug development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Astellas Pharma, Inc. (Japan) - Pfizer, Inc. (U.S.) - Teva Pharmaceutical Industries Limited (Israel) - Allergan, Plc (Ireland) - Medtronic plc (Ireland) - Mylan N.V. (U.S.) - En......
  • Global Abdominal Aortic Aneurysm Drug Sales Market Report 2017
    Published: 13-Dec-2017        Price: US 4000 Onwards        Pages: 108
    In this report, the global Abdominal Aortic Aneurysm Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Abdominal Aortic Aneurysm Drug for these regions, from 2012 to 2022 (forecast), covering - United States - China ......
  • Global Acinetobacter Infections Treatment Sales Market Report 2017
    Published: 13-Dec-2017        Price: US 4000 Onwards        Pages: 113
    In this report, the global Acinetobacter Infections Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Acinetobacter Infections Treatment for these regions, from 2012 to 2022 (forecast), covering - United States - China......
  • United States Venous Stents Market Report 2017
    Published: 13-Dec-2017        Price: US 3800 Onwards        Pages: 102
    In this report, the United States Venous Stents market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of Ve......
  • Global Adrenocorticotropic Hormone Receptor Sales Market Report 2017
    Published: 13-Dec-2017        Price: US 4000 Onwards        Pages: 100
    In this report, the global Adrenocorticotropic Hormone Receptor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Adrenocorticotropic Hormone Receptor for these regions, from 2012 to 2022 (forecast), covering - United States - C......
  • United States Injectable Fillers Market Report 2017
    Published: 13-Dec-2017        Price: US 3800 Onwards        Pages: 104
    In this report, the United States Injectable Fillers market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate ......
  • United States Sheep Placenta Extract Market Report 2017
    Published: 13-Dec-2017        Price: US 3800 Onwards        Pages: 110
    In this report, the United States Sheep Placenta Extract market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth r......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs